BR112023005376A2 - Composições de oligossacarídeos e métodos de uso - Google Patents

Composições de oligossacarídeos e métodos de uso

Info

Publication number
BR112023005376A2
BR112023005376A2 BR112023005376A BR112023005376A BR112023005376A2 BR 112023005376 A2 BR112023005376 A2 BR 112023005376A2 BR 112023005376 A BR112023005376 A BR 112023005376A BR 112023005376 A BR112023005376 A BR 112023005376A BR 112023005376 A2 BR112023005376 A2 BR 112023005376A2
Authority
BR
Brazil
Prior art keywords
methods
compositions
oligosaccharides
oligosaccharide compositions
oligosaccharide
Prior art date
Application number
BR112023005376A
Other languages
English (en)
Inventor
Meisner Jeffrey
Matthew Liu Christopher
Rosini Madeline
Hecht Max
Humphries Eric
Jose Adarsh
Van Hylckama Vlieg Johan
Dowling Mark
Wingertzahn Mark
Lee Jackson
Original Assignee
Dsm Nutritional Products Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Nutritional Products Llc filed Critical Dsm Nutritional Products Llc
Publication of BR112023005376A2 publication Critical patent/BR112023005376A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04—Disaccharides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

COMPOSIÇÕES DE OLIGOSSACARÍDEOS E MÉTODOS DE USO. Aspectos da divulgação referem-se a composições de oligossacarídeos e métodos para preparar as mesmas. Também são fornecidos métodos de uso de composições de oligossacarídeos como terapias metabólicas de microbioma para diminuir a inflamação para o tratamento de distúrbios e doenças inflamatórias e imunológicas.
BR112023005376A 2020-09-25 2021-09-24 Composições de oligossacarídeos e métodos de uso BR112023005376A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063083796P 2020-09-25 2020-09-25
PCT/US2021/052098 WO2022067131A1 (en) 2020-09-25 2021-09-24 Oligosaccharide compositions and methods of use

Publications (1)

Publication Number Publication Date
BR112023005376A2 true BR112023005376A2 (pt) 2023-04-25

Family

ID=80845871

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023005376A BR112023005376A2 (pt) 2020-09-25 2021-09-24 Composições de oligossacarídeos e métodos de uso

Country Status (8)

Country Link
EP (1) EP4216727A4 (pt)
JP (1) JP2023542536A (pt)
KR (1) KR20230076828A (pt)
CN (1) CN116490192A (pt)
AU (1) AU2021350104A1 (pt)
BR (1) BR112023005376A2 (pt)
CA (1) CA3196600A1 (pt)
WO (1) WO2022067131A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113163828B (zh) 2018-08-15 2024-04-26 剑桥糖质科学有限公司 新型组合物、其用途及其形成方法
WO2021032647A1 (en) 2019-08-16 2021-02-25 Cambridge Glycoscience Ltd Methods of treating biomass to produce oligosaccharides and related compositions
BR112022011603A2 (pt) 2019-12-12 2022-08-30 Cambridge Glycoscience Ltd Produtos alimentícios multifase com baixo teor de açúcar
WO2023242194A1 (en) * 2022-06-14 2023-12-21 Dsm Ip Assets B.V. Separation of human milk oligosaccharides from a fermentation broth
WO2024043298A1 (ja) * 2022-08-25 2024-02-29 株式会社明治 腸内細菌叢改善用組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3071235T1 (en) * 2015-01-26 2018-04-30 Kaleido Biosciences, Inc. THERAPEUTIC GLITTERS AND THE RELATED METHOD
US20180147221A1 (en) * 2015-04-23 2018-05-31 Kaleido Biosciences, Inc. Glycan therapeutic compositions and related methods thereof
US20180296582A1 (en) * 2015-04-23 2018-10-18 Kaleido Biosciences, Inc. Microbiome regulators and related uses thereof
JP2020513410A (ja) * 2016-12-06 2020-05-14 カレイド・バイオサイエンシズ・インコーポレイテッド グリカンポリマーおよびその関連方法
CN113056488B (zh) * 2018-08-21 2023-10-24 Dsm营养产品有限责任公司 寡糖组合物及其用于降低氨水平的使用方法
SG11202104207TA (en) * 2018-11-08 2021-05-28 Kaleido Biosciences Inc Oligosaccharide compositions and methods of use thereof

Also Published As

Publication number Publication date
CA3196600A1 (en) 2022-03-31
CN116490192A (zh) 2023-07-25
EP4216727A4 (en) 2024-10-23
AU2021350104A1 (en) 2023-06-08
WO2022067131A9 (en) 2022-05-05
EP4216727A1 (en) 2023-08-02
WO2022067131A1 (en) 2022-03-31
AU2021350104A9 (en) 2024-05-23
KR20230076828A (ko) 2023-05-31
JP2023542536A (ja) 2023-10-10

Similar Documents

Publication Publication Date Title
BR112023005376A2 (pt) Composições de oligossacarídeos e métodos de uso
PH12020500240A1 (en) Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies
SA518392101B1 (ar) ROR-Gamma مشتقات البنزيميدازول في صورة مُعدلات لـ
SA518391624B1 (ar) Ror- منظمات جاما
CO2018005361A2 (es) Formulaciones inyectables de toxina botulínica y sus métodos de uso que poseen efecto terapéutico o cosmético de larga duración
MX2017005030A (es) Composiciones y metodos para el tratamiento de la disfusion de la glandula de meibomio.
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
BR112015011933A2 (pt) composições bacterianas sinérgicas e métodos de produção e uso das mesmas
BR112015021888A8 (pt) inibidores de dna-pk, seus usos e composição farmacêutica
EA201692422A1 (ru) Состав, содержащий пролекарство гемцитабина
BR112019022901A2 (pt) precursor de linhagem mesenquimal ou células t com imunossupressão intensificada
BR112015018270A2 (pt) composições que compreendem 15-ohepa e métodos de uso das mesmas
PH12021550872A1 (en) Therapeutic compounds
PL410665A1 (pl) Inhibitory arginazy oraz ich zastosowania terapeutyczne
WO2015031765A3 (en) Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections
EA201791814A1 (ru) Имидазолильные трициклические еноны как антиоксидантные модуляторы воспаления
WO2018094300A8 (en) ANTI-GITR ANTIGEN BINDING PROTEINS AND METHODS OF USE
BR112014030534A2 (pt) composições de galacto-ramnogalacturonato para o tratamento de doenças associadas com óxido nítrico sintase induzível elevada
BR112022012684A2 (pt) Compostos cíclicos e métodos de uso dos mesmos
WO2020097568A3 (en) Oligosaccharide compositions and methods of use thereof
WO2020128070A3 (de) Kollagenhydrolysat zur verwendung gegen hautkrankheiten und darmkrankheiten
MX2021003643A (es) Derivados de terpenoides y usos de los mismos.
BR112021022293A2 (pt) Composições de oligossacarídeos e métodos de uso das mesmas
BR112016004904A8 (pt) moduladores de receptor x do fígado (lxr), composição farmacêutica, seus usos e método para modular atividade de lxr
WO2020041531A3 (en) Oligosaccharide compositions and methods of use thereof for reducing ammonia levels